1 – 10 of 200
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Conservation of Bacterial Lipopolysaccharide Binding by SARS-CoV-2 Spike across Major Viral Variants
- Contribution to journal › Article
-
Mark
Non-invasive Analysis of Skin in Recessive Dystrophic Epidermolysis Bullosa Using High-Frequency Ultrasound : A First Case Report
- Contribution to journal › Article
-
Mark
A First-In-Human Randomized Controlled Phase 1 Study Assessing the Safety and Tolerability of Topical TCP-25 Gel in Epidermal Suction Blister Wounds
- Contribution to journal › Article
-
Mark
The conserved N-terminal histidine in an engineered peptide mediates sepsis treatment efficacy via dual binding to CD14 and LPS
- Contribution to journal › Article
-
Mark
Colostomy May Improve Outcomes in Patients with Severe Anogenital and Gluteal Hidradenitis Suppurativa : Case Series
- Contribution to journal › Article
- 2025
-
Mark
Editorial : Advancements in translational models: bridging basic infection research and clinical applications
- Contribution to journal › Debate/Note/Editorial
-
Mark
Mass spectrometry peptidomics data from infected and uninfected porcine wounds
- Contribution to journal › Article
-
Mark
Pseudomonas aeruginosa elastase down-regulates host inflammatory responses by degrading cytokines and chemokines : a non-healing wound perspective
- Contribution to journal › Article
-
Mark
Results of a non-randomized, open-label phase I study evaluating the novel Immunomodulatory peptide TCP-25 for treatment of dystrophic epidermolysis bullosa
(2025) In Orphanet Journal of Rare Diseases
- Contribution to journal › Article
-
Mark
A murine pressure ulcer model for evaluating persistence and treatment of Staphylococcus aureus infection
- Contribution to journal › Article
